Finally, several genes in the [NASH]vs[NAFLD + HC] signature (e.g. CHST9, DPYSL2) have not been previously implicated in liver disease and could potentially provide novel biological insights into NASH etiology. The gene discussed is DPYSL2; the disease is metabolic dysfunction-associated steatotic liver disease.